Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients

Thromboprophylaxis in Patients with COVID-19. A Brief Update to the CHEST Guideline and Expert Panel Report

(2022) Lisa K. Moores et al.   CHEST

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients

(2021) Yu Zuo et al.   Scientific Reports

Proximal deep vein thrombosis and pulmonary embolism in COVID-19 patients: a systematic review and meta-analysis

(2021) Gregoire Longchamp et al.   Thrombosis Journal

Cardiovascular and Cerebrovascular Complications With COVID-19

(2021) Arielle Greenberg et al.   Cardiology in Review

Mechanisms of thrombosis and cardiovascular complications in COVID-19

(2021) Eden M. Page et al.   THROMBOSIS RESEARCH

The Central Role of PAI-1 in COVID-19: Thrombosis and beyond

(2021) Sadiya S. Khan   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Surviving Covid-19 with Heparin?

(2021) Hugo ten Cate   NEW ENGLAND JOURNAL OF MEDICINE

Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients

(2021) Yael Lichter et al.   Thrombosis Journal

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

(2020) Ning Tang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Hematological findings and complications of COVID ‐19

(2020) Evangelos Terpos et al.   AMERICAN JOURNAL OF HEMATOLOGY

Delayed‐Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID‐19)

(2020) Wanxin Chen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection

(2020) Huan Han et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?

(2020) Clara Benedetta Conti et al.   European Journal of Internal Medicine

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

(2020) Julie Helms et al.   INTENSIVE CARE MEDICINE

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

(2020) Behnood Bikdeli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Thrombin generation predicts for early recurrence in breast cancer patients

(2020) Marina Marchetti et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Hypercoagulability of COVID‐19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis

(2020) Mauro Panigada et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

(2020) Jecko Thachil et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors

(2020) Mathieu Artifoni et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Thromboprophylaxis in COVID-19: Anti-FXa—the Missing Factor?

(2020) Tina Dutt et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

(2020) Hanny Al-Samkari et al.   BLOOD

Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis

(2020) Christophe Nougier et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

(2020) Yan Zhang et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis

(2020) B. Mestre-Gómez et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility

(2020) Hong-Long Ji et al.   PHYSIOLOGICAL REVIEWS

Bleeding and Bleeding Risk in COVID-19

(2020) Akbar Dorgalaleh   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis

(2020) F.A. Klok et al.   THROMBOSIS RESEARCH

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

(2020) F.A. Klok et al.   THROMBOSIS RESEARCH

Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study

(2020) Danying Liao et al.   Lancet Haematology

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

(2020) George Goshua et al.   Lancet Haematology

COVID-19 coagulopathy vs disseminated intravascular coagulation

(2020) Marcel Levi   Blood Advances

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) – anatomic pathology perspective on current knowledge

(2020) Sambit K. Mohanty et al.   Diagnostic Pathology

Evaluation of COVID‐19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays

(2020) Danielle White et al.   International Journal of Laboratory Hematology

Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus

(2020) Upendra K. Katneni et al.   THROMBOSIS AND HAEMOSTASIS

Mechanisms involved in the development of thrombocytopenia in patients with COVID-19

(2020) Yujiao Zhang et al.   THROMBOSIS RESEARCH

Pulmonary Thrombosis or Embolism in a Large Cohort of Hospitalized Patients With Covid-19

(2020) Natividad Benito et al.   Frontiers in Medicine

The Coagulation and Immune Systems Are Directly Linked through the Activation of Interleukin-1α by Thrombin

(2019) Laura C. Burzynski et al.   IMMUNITY

The Role of Interleukin 6 During Viral Infections

(2019) Lauro Velazquez-Salinas et al.   Frontiers in Microbiology

Recognition of plasminogen activator inhibitor type 1 as the primary regulator of fibrinolysis

(2019) Tetsumei Urano et al.   CURRENT DRUG TARGETS

Platelets Are Critical Key Players in Sepsis

(2019) Fanny Vardon-Bounes et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Coagulation factors VII, IX and X are effective antibacterial proteins against drug-resistant Gram-negative bacteria

(2019) Jinwu Chen et al.   CELL RESEARCH

Thrombin contributes to protective immunity in pneumonia-derived sepsis via fibrin polymerization and platelet-neutrophil interactions

(2017) T. A. M. Claushuis et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII

(2016) D. C. Rijken et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Diagnosis and Management of Congenital and Acquired FXIII Deficiencies

(2016) Éva Katona et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Newly-Recognized Roles of Factor XIII in Thrombosis

(2016) James Byrnes et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Coagulation factor XIIIa is inactivated by plasmin

(2015) W. S. Hur et al.   BLOOD

The role of platelets in sepsis

(2014) Cornelis van ’t Veer et al.   THROMBOSIS AND HAEMOSTASIS

Tissue-regenerating functions of coagulation factor XIII

(2013) C. Soendergaard et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Acute Respiratory Distress Syndrome

(2012)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Recombinant Factor XIII Mitigates Hemorrhagic Shock-Induced Organ Dysfunction

(2011) Sergey B. Zaets et al.   JOURNAL OF SURGICAL RESEARCH

Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury

(2009) Anil Sapru et al.   INTENSIVE CARE MEDICINE